Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

AMD Today: 2nm ‘Venice’ CPUs & MI400 AI Accelerators Confirmed for 2026 as Shares Flicker Ahead of Nov. 11 Analyst Day

AMD Today: 2nm ‘Venice’ CPUs & MI400 AI Accelerators Confirmed for 2026 as Shares Flicker Ahead of Nov. 11 Analyst Day

Advanced Micro Devices, Inc. (NASDAQ: AMD) headlines today with fresh confirmation that its next big data‑center leap—2nm “Epyc Venice” CPUs and Instinct MI400 accelerators—is slated for 2026, while investors count down to AMD’s Financial Analyst Day on Tuesday, November 11.
Crypto Markets Today (Nov 7, 2025): ‘Extreme Fear’ Lingers as ETFs Snap Outflow Streak; Research Confirms First Red October Since 2018

Crypto Markets Today (Nov 7, 2025): ‘Extreme Fear’ Lingers as ETFs Snap Outflow Streak; Research Confirms First Red October Since 2018

Crypto sentiment remains fragile to end the week, but there are early signs of stabilization after days of risk-off trading. A key sentiment gauge has swung to “Extreme Fear”, while spot crypto ETFs notched fresh inflows on Thursday, Nov. 6,
7 November 2025
Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

The Wendy’s Company (NASDAQ: WEN) beat Q3 estimates, declared a $0.14 dividend, outlined 2025 guidance, and said a mid‑single‑digit percentage of U.S. restaurants could close under its new “Project Fresh” turnaround. Here’s what investors need to know today. Wendy’s delivered
Intellia Therapeutics (NTLA) plunges after patient death in pivotal CRISPR trial; Q3 update, analyst downgrades and what to watch next [Nov. 7, 2025]

Intellia Therapeutics (NTLA) plunges after patient death in pivotal CRISPR trial; Q3 update, analyst downgrades and what to watch next [Nov. 7, 2025]

What happened today Intellia Therapeutics (NASDAQ: NTLA) is under intense pressure after the company said the patient who experienced Grade 4 liver enzyme and bilirubin elevations in its Phase 3 MAGNITUDE study later died. In a Nov. 6 business update,
Airbnb (ABNB) Q3 2025 Results: 10% Revenue Growth and Upbeat Holiday Outlook — What It Means for the Stock Today

Airbnb (ABNB) Q3 2025 Results: 10% Revenue Growth and Upbeat Holiday Outlook — What It Means for the Stock Today

Airbnb, Inc. (NASDAQ: ABNB) is in focus today after posting solid third‑quarter numbers and guiding to a slightly stronger‑than‑expected holiday quarter, helped by international demand and a new “Reserve Now, Pay Later” option that’s pulling bookings forward. Investors are parsing
Sweetgreen (NYSE: SG) Cuts 2025 Outlook, Sells Spyce Robotics to Wonder for $186.4M After Weak Q3 — 11/7/2025

Sweetgreen (NYSE: SG) Cuts 2025 Outlook, Sells Spyce Robotics to Wonder for $186.4M After Weak Q3 — 11/7/2025

What happened Sweetgreen reported third‑quarter FY2025 revenue of $172.4 million, down 0.6% year over year. Same‑store sales fell 9.5%, driven by an 11.7% drop in traffic and product mix, partly offset by 2.2% of price increases. Digital remained a majority
IREN Limited (NASDAQ: IREN) Posts Record Q1, Lands $9.7B Microsoft AI Cloud Deal — Stock Swings as Compass Point Doubles Target to $105 (Nov. 7, 2025)

IREN Limited (NASDAQ: IREN) Posts Record Q1, Lands $9.7B Microsoft AI Cloud Deal — Stock Swings as Compass Point Doubles Target to $105 (Nov. 7, 2025)

IREN Limited — the AI-focused data‑center operator formerly known as Iris Energy — is back in the spotlight today after reporting record fiscal Q1 FY26 results last night and riding momentum from a $9.7 billion, five‑year AI cloud contract with
1 63 64 65 66 67 232
Go toTop